Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis
- PMID: 1687783
- DOI: 10.1007/978-3-7091-9175-0_26
Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis
Abstract
There is evidence to suggest that glutamate and other excitatory amino acids play an important role in the regulation of neuronal excitation. Glutamate receptor stimulation leads to a non-physiological increase of intracellular free Ca2+. Disturbed Ca2+ homeostasis and subsequent radical formation may be decisive factors in the pathogenesis of neurodegenerative diseases. Decreased glutamatergic activity appears to contribute to paranoid hallucinatory psychosis in schizophrenia and pharmacotoxic psychosis in Parkinson's disease. It has been suggested that a loss of glutamatergic function causes dopaminergic over-activity. Imbalances of glutamatergic and dopaminergic systems in different brain regions may result in anti-akinetic effects or the occurrence of psychosis. The simplified hypothesis of a glutamatergic-dopaminergic (im)-balance may lead to a better understanding of motor behaviour and psychosis.
Similar articles
-
Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia.Arzneimittelforschung. 1992 Feb;42(2A):265-8. Arzneimittelforschung. 1992. PMID: 1350197 Review.
-
Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity.FASEB J. 1990 Jul;4(10):2789-97. doi: 10.1096/fasebj.4.10.2165013. FASEB J. 1990. PMID: 2165013 Review.
-
Ganglioside-mediated protection from glutamate-induced neuronal death.Acta Neurobiol Exp (Wars). 1990;50(4-5):475-88. Acta Neurobiol Exp (Wars). 1990. PMID: 1983378 Review.
-
Calcium and glutamate-induced cortical neuronal death.Res Publ Assoc Res Nerv Ment Dis. 1993;71:23-34. Res Publ Assoc Res Nerv Ment Dis. 1993. PMID: 8093332 Review. No abstract available.
-
Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?Biol Psychiatry. 1992 Feb 15;31(4):337-50. doi: 10.1016/0006-3223(92)90227-q. Biol Psychiatry. 1992. PMID: 1348429 Review.
Cited by
-
Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review.J Neural Transm (Vienna). 2008;115(3):493-511. doi: 10.1007/s00702-007-0859-5. Epub 2008 Feb 26. J Neural Transm (Vienna). 2008. PMID: 18301955
-
The Function of the Mitochondrial Calcium Uniporter in Neurodegenerative Disorders.Int J Mol Sci. 2017 Feb 10;18(2):248. doi: 10.3390/ijms18020248. Int J Mol Sci. 2017. PMID: 28208618 Free PMC article. Review.
-
Neuroprotective strategies in Parkinson's disease : an update on progress.CNS Drugs. 2003;17(10):729-62. doi: 10.2165/00023210-200317100-00004. CNS Drugs. 2003. PMID: 12873156 Review.
-
Comparison of the anticonvulsive activities of organic mono- and dications with their abilities to inhibit NMDA and AMPA glutamate receptors.Neurosci Behav Physiol. 2004 Feb;34(2):181-7. doi: 10.1023/b:neab.0000009212.61235.ed. Neurosci Behav Physiol. 2004. PMID: 15115325
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous